Skip to main content
NHS National Services Scotland Home
FOI release

FOI – 2026-3525 Medicines used to treat haemophilia A, haemophilia B and von Willebrand disease

Published on 05 November 2026

From: National Procurement and Logistics

Information request and response for FOI Reference: FOI – 2026-3525

Documents

FOI – 2026-3525 Medicines Used To Treat Haemophilia A, Haemophilia B And Von Willebrand Disease

FOI – 2026-3525 Appendix 1: Coagulation Factors Homecare Uptake Summary 2021-2025

FOI – 2026-3525 Appendix 2: Coagulation Factors 2021–2025

Details

Freedom of Information Reference: FOI – 2026-3525 Medicines used to treat haemophilia A, haemophilia B and von Willebrand disease.

Public Services Delivery Scotland (PSDS) is committed to publishing all information released in response to Freedom of Information requests. You can view all FOI responses within our FOI Publications repository.

Some document formats on nss.nhs.scot such as PDF, MS Word and Excel may not be fully accessible. Where possible we make documents accessible and/or provide a suitable HTML alternative.